Northpond Ventures, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Candel Therapeutics, Inc. Common Stock, $0.01 par value per share (CADL)

Filing Manager
Northpond Ventures, LP
Reporting Manager
Northpond Ventures, LP
Security
Candel Therapeutics, Inc. Common Stock, $0.01 par value per share
Symbol
CADL
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:32:44 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Northpond Ventures, LP 0% 0 0 0 /s/ Patrick Smerkers By: Northpond Ventures GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures GP, LLC 0% 0 0 0 /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Northpond Ventures II, LP 0% 0 0 0 /s/ Patrick Smerkers By: Northpond Ventures II GP, LLC, its General Partner, By Patrick Smerkers, Authorized Signatory
Northpond Ventures II GP, LLC 0% 0 0 0 /s/ Patrick Smerkers By Patrick Smerkers, Authorized Signatory
Michael P. Rubin 0% 0 0 0 /s/ Michael P. Rubin Michael P. Rubin, Self